Transmission of mumps virus from mumps-vaccinated individuals to close contacts

Municipal Health Service "Midden-Nederland", Zeist, The Netherlands.
Vaccine (Impact Factor: 3.62). 11/2011; 29(51):9551-6. DOI: 10.1016/j.vaccine.2011.09.100
Source: PubMed

ABSTRACT During a recent mumps epidemic in the Netherlands caused by a genotype D mumps virus strain, we investigated the potential of vaccinated people to spread mumps disease to close contacts. We compared mumps viral titers of oral fluid specimens obtained by quantitative PCR from vaccinated (n=60) and unvaccinated (n=111) mumps patients. We also investigated the occurrence of mumps infection among the household contacts of vaccinated mumps patients. We found that viral titers are higher for unvaccinated patients than for vaccinated patients during the 1st 3 days after onset of disease. While no symptomatic cases were reported among the household contacts (n=164) of vaccinated mumps patients (n=36), there were cases with serological evidence of asymptomatic infection among vaccinated household contacts (9 of 66 vaccinated siblings). For two of these siblings, the vaccinated index patient was the most probable source of infection. We conclude that, in this particular outbreak, the risk of a close contact becoming infected by vaccinated patients was small, but present.

Download full-text


Available from: Ewout Fanoy, Feb 24, 2014
26 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: To estimate the mumps vaccine effectiveness (VE) during a large genotype D mumps outbreak, we conducted a cross-sectional study in eight primary schools and associated households in the Netherlands. Questionnaires were used to collect information on the occurrence of mumps. Multivariate analyses were used to estimate VE. Among schoolchildren we estimated the VE against mumps. Among household contacts where the schoolchild was the index case we estimated the VE against mumps and against mumps infectiousness. In total 1175 children and 2281 household contacts participated in the study. The mumps attack rate among schoolchildren was 17%. The mumps VE in schoolchildren was 92% [95% confidence interval (CI) 83-96%] and 93% [85-97%] for one and two doses of the measles, mumps, rubella (MMR) vaccine, respectively. The adjusted mumps VE among household contacts was 67% [65-95%] and 11% [-4 to 88%] against mumps and mumps infectiousness, respectively. Our study indicates that the mumps component of the MMR vaccine offered adequate protection against mumps among schoolchildren. The relatively low VE among household contacts is of concern.
    Vaccine 02/2012; 30(19):2999-3002. DOI:10.1016/j.vaccine.2012.02.035 · 3.62 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Here we present mumps virus specific antibody levels in a large cross-sectional population-based serosurveillance study performed in the Netherlands in 2006/2007 (n = 7900). Results were compared with a similar study (1995/1996) and discussed in the light of recent outbreaks. Mumps antibodies were tested using a fluorescent bead-based multiplex immunoassay. Overall seroprevalence was 90.9% with higher levels in the naturally infected cohorts compared with vaccinated cohorts. Mumps virus vaccinations at 14 months and 9 years resulted in an increased seroprevalence and antibody concentration. The second vaccination seemed to be important in acquiring stable mumps antibody levels in the long term. In conclusion, the Dutch population is well protected against mumps virus infection. However, we identified specific age- and population groups at increased risk of mumps infection. Indeed, in 2007/2008 an outbreak has occurred in the low vaccination coverage groups emphasizing the predictive value of serosurveillance studies.
    PLoS ONE 03/2013; 8(3):e58234. DOI:10.1371/journal.pone.0058234 · 3.23 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In 2009-2010, we investigated a mumps outbreak among a highly vaccinated Orthodox Jewish population in a village in Orange County (OC), New York, to identify risk factors associated with mumps transmission among persons with two doses of mumps-containing vaccine. Demographic and epidemiologic characteristics were collected on students in grades 6-12 in three schools. A mumps case was defined as a student, who self-reported parotitis, orchitis, jaw swelling, and/or a mumps-related complication or whose mumps illness was reported to the OC Health Department during September 1, 2009-January 18, 2010. Log-binomial regression analyses were conducted separately for boys and girls as they attended different schools and had different hours of study. Of the 2503 students with two documented doses of mumps-containing vaccine, 320 (13%) developed mumps. Risk of mumps increased with increasing number of mumps cases in the class [≥8versus ≤3 cases: boys aRR=3.1 (95% CI: 2.0-5.0); girls aRR=2.6 (95% CI: 1.6-4.1)] and household [>1 versus 0 cases: boys aRR=4.3 (95%CI: 3.7-5.6); girls aRR=10.1 (95%CI: 7.1-14.3)]. Age at first dose, time since last dose, time between first and second dose, school, class size, number of hours at school per week, and household size were not significantly associated with having mumps. Two doses of mumps-containing vaccine may not be as effective in outbreak settings with multiple, prolonged, and intense exposure. Additional studies are required to understand why such mumps outbreaks occur and how they can be prevented in the future.
    The Pediatric Infectious Disease Journal 08/2013; 33(2). DOI:10.1097/INF.0000000000000020 · 2.72 Impact Factor
Show more